McDonald’s tests high-protein menu as users of weight-loss drug GLP-1 increase

McDonald’s tests high-protein menu as users of weight-loss drug GLP-1 increase

McDonald’s Corporation (NYSE:MCD) is adapting its menu as a growing number of Americans taking GLP-1 weight-loss drugs, such as Ozempic and Wegovy, modify portion sizes, snacking habits and beverage choices. During an earnings conference call on Wednesday, CEO Chris Kempczinski He said McDonald’s is testing menu items to appeal to customers who take GLP-1 medications….

Read More
McDonald’s has a big problem with its customers

McDonald’s has a big problem with its customers

McDonald’s is one of the most popular restaurants in the world, but the company has recently witnessed a worrying shift in customer behavior as the economy puts pressure on many of its customers, forcing them to reduce their visits. Customers can’t be blamed, as prices in the quick service restaurant (QSR) industry have increased significantly,…

Read More